Using the Crystal Ball: What Does the Future Hold for Life Science…
Recently, as part of the course Legal Compliance Essentials for Drug, Device and Biotech Companies, Mitchell Hamline Law…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Dr. Janet Woodcock on the Opioid Epidemic
The United States Food and Drug Administration (FDA) offers a podcast series, known as the Director’s Corner, that features the…
2016-2025 Projections of National Health Expenditures Data Released
National health expenditure is expected to grow an average of 5.6% annually from 2016 through 2025, according to a report…
Accountability: The shifting landscape of compliance responsibilities
The meaning of effectiveness of healthcare compliance programs has shifted in recent years. This article examines that…
Op-Ed in The Hill on Allowing Medicare to Directly Negotiate Drug Prices
Dr.Rafael Fonseca, a Chair of the Department of Medicine at the Mayo Clinic in Arizona and Distinguished Mayo Investigator,…
Privacy Regulation: The Final Frontier of Life Science Compliance
Recently, as part of the course Legal Compliance Essentials for Drug, Device and Biotech Companies, Mitchell Hamline…
OIG Raises Concerns Regarding Accuracy of New Clinical Laboratory Payment…
In early October, the Office of Inspector General (OIG) released a report monitoring the progress made by the Centers for Medicare…
MedPAC Considers Revised Approaches to Part B Drug Payment
In mid-January, the Medicare Payment Advisory Commission (MedPAC) met and discussed a revised approach to clinician payment for…
CMS Releases Report on Drug Rebates
The Centers for Medicare and Medicaid Services (CMS) has released a new report highlighting the growth in rebates from drug…
Healthcare Providers Accused of $100 Million Kickback Scheme
A dozen doctors, pharmacy owners, and marketing professionals have been accused of being involved in a sham medical…